In clinical trials, participants who took the highest dose of the pill lost an average of 16.6 percent of their body weight (approximately 32 pounds for a 200-pound person) after 64 weeks, the drugs manufacturer, Novo Nordisk, said in a Dec
Are more patients with obesity opting for GLP-1 drugs over other weight-loss options, including lifestyle changes or bariatric procedures
Additionally, most providers may prefer a once-weekly schedule with titration adjusted based on clinical judgment
When Retatrutides weight loss curve flattens, adding AOD-9604 introduces a new stimulus that the body has not adapted to yet
Patients without confirmed deficiency but with risk factors may benefit from prophylactic oral B12 supplementation (typically 50150 micrograms daily), though this should be discussed with their healthcare provider rather than self-initiated